INTERNATIONAL PATENT: GANYMEDE ONCOLOGY, INC. FILES APPLICATION FOR "(HETERO)ARYL AND INDOLINYL NRF2 PROTEIN DEGRADERS"

GENEVA, July 3 -- GANYMEDE ONCOLOGY, INC. (BioLabs San Diego9276 Scranton Rd. Suite 500San Diego, California 92121) filed a patent application (PCT/US2024/061543) for "(HETERO)ARYL AND INDOLINYL NRF2 PROTEIN DEGRADERS" on Dec 20, 2024. With publication no. WO/2025/137626, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MUNROE, John Edwin (1205 Pacific Hwy. #2906San Diego, California 92101)

Abstract: The present disclosure provides compounds represented by Formula (IV): (IV), and the salts or solvates thereof, wherein R...